OBJECTIVE: It is controversial whether the clustering of certain metabolic abnormalities should be separately designated as the metabolic syndrome. We operationalized the "syndrome" concept and tested whether the metabolic syndrome was compatible with these operational constructs. RESEARCH DESIGN AND METHODS: The baseline cross-section of the Multi-Ethnic Study of Atherosclerosis recruited a population-based cohort of 6,781 individuals, aged 45-84 years, from six communities in the U.S. Metabolic syndrome components (waist circumference, blood pressure, fasting serum HDL cholesterol, triglycerides, and plasma glucose), homeostasis model assessment (HOMA) of insulin resistance (fasting glucose x insulin), and intimal-medial thickness (IMT) in the common and internal carotid arteries by B-mode ultrasound were measured. RESULTS: Higher syndrome component count is associated with higher HOMA levels (trend P < 0.001). Given the prevalence of individual components, the nonprevalence of any component or the co-prevalence of four or five components is greater than expected (chi2 P < 0.001). After accounting for the additive association of each component, the current definition of metabolic syndrome (co-prevalence of three or more components) does not have supra-additive association with thicker IMT in the common carotid (men: P = 0.075, women: P = 0.949) or internal carotid artery (men: P = 0.106, women: P = 0.121). CONCLUSIONS: The metabolic syndrome did not have supra-additive association with IMT, but its components clustered greater than chance expectation and a higher component count was associated with greater insulin resistance. The metabolic syndrome was compatible with two of three "syndrome" constructs tested.
OBJECTIVE: It is controversial whether the clustering of certain metabolic abnormalities should be separately designated as the metabolic syndrome. We operationalized the "syndrome" concept and tested whether the metabolic syndrome was compatible with these operational constructs. RESEARCH DESIGN AND METHODS: The baseline cross-section of the Multi-Ethnic Study of Atherosclerosis recruited a population-based cohort of 6,781 individuals, aged 45-84 years, from six communities in the U.S. Metabolic syndrome components (waist circumference, blood pressure, fasting serum HDL cholesterol, triglycerides, and plasma glucose), homeostasis model assessment (HOMA) of insulin resistance (fasting glucose x insulin), and intimal-medial thickness (IMT) in the common and internal carotid arteries by B-mode ultrasound were measured. RESULTS:Higher syndrome component count is associated with higher HOMA levels (trend P < 0.001). Given the prevalence of individual components, the nonprevalence of any component or the co-prevalence of four or five components is greater than expected (chi2 P < 0.001). After accounting for the additive association of each component, the current definition of metabolic syndrome (co-prevalence of three or more components) does not have supra-additive association with thicker IMT in the common carotid (men: P = 0.075, women: P = 0.949) or internal carotid artery (men: P = 0.106, women: P = 0.121). CONCLUSIONS: The metabolic syndrome did not have supra-additive association with IMT, but its components clustered greater than chance expectation and a higher component count was associated with greater insulin resistance. The metabolic syndrome was compatible with two of three "syndrome" constructs tested.
Authors: Maciste H Macias-Cervantes; Juan M Malacara; Ma Eugenia Garay-Sevilla; Francisco J Díaz-Cisneros Journal: Eur J Pediatr Date: 2009-01-14 Impact factor: 3.183
Authors: Nathan D Wong; Jennifer C Nelson; Tanya Granston; Alain G Bertoni; Roger S Blumenthal; J Jeffrey Carr; Alan Guerci; David R Jacobs; Richard Kronmal; Kiang Liu; Mohammed Saad; Elizabeth Selvin; Russell Tracy; Robert Detrano Journal: JACC Cardiovasc Imaging Date: 2012-04
Authors: Aldi T Kraja; Dhananjay Vaidya; James S Pankow; Mark O Goodarzi; Themistocles L Assimes; Iftikhar J Kullo; Ulla Sovio; Rasika A Mathias; Yan V Sun; Nora Franceschini; Devin Absher; Guo Li; Qunyuan Zhang; Mary F Feitosa; Nicole L Glazer; Talin Haritunians; Anna-Liisa Hartikainen; Joshua W Knowles; Kari E North; Carlos Iribarren; Brian Kral; Lisa Yanek; Paul F O'Reilly; Mark I McCarthy; Cashell Jaquish; David J Couper; Aravinda Chakravarti; Bruce M Psaty; Lewis C Becker; Michael A Province; Eric Boerwinkle; Thomas Quertermous; Leena Palotie; Marjo-Riitta Jarvelin; Diane M Becker; Sharon L R Kardia; Jerome I Rotter; Yii-Der Ida Chen; Ingrid B Borecki Journal: Diabetes Date: 2011-03-08 Impact factor: 9.461
Authors: Virgínia Genelhu de Abreu; Cyro José de Moraes Martins; Patricia Aguiar Cardoso de Oliveira; Emilio Antonio Francischetti Journal: PLoS One Date: 2017-07-26 Impact factor: 3.240